Intellia Therapeutics, Inc. (NTLA) Reports Q1 Loss, Tops Revenue Estimates

Intellia Therapeutics, Inc. (NTLA) came out with a quarterly loss of $1.06 per share versus the Zacks Consensus Estimate of a loss of$ 1.35. This compares to loss of $1.17 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 21.48%. A quarter ago, it was expected that this company would post a loss of$ 1.47 per share when it actually produced a loss of $1.46, delivering a surprise of 0.68%.Over the last four quarters, the company h ...